Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver

Oncogene. 2020 Jun;39(23):4619. doi: 10.1038/s41388-020-1310-8.

M J Gray¹, N A Dallas², G Van Buren², L Xia³, A D Yang², R J Somcio³, P Gaur², L S Mangala⁴, P E Vivas-Mejia⁵, F Fan³, A M Sanguino⁵, G E Gallick³, G Lopez-Berestein⁵, A K Sood^{3

4}, L M Ellis^{6

7}

¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. [email protected].
² Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁶ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. [email protected].
⁷ Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. [email protected].

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.